Home » Featured » Page 24
Featured
A budget push from U.S. Sens. Richard Shelby (R-AL), Jim Inhofe (R-OK), and Roger Wicker (R-MS) seeks to require the Senate Armed Services Committee (SASC) to report reconciliation legislation of $50.2 billion for military infrastructure improvements, among other items.
If accepted, their... Read More »
Regulatory approval was granted for two new clinical trials of INO-4800 in China this week, allowing its creator INOVIO and its partners Advaccine Biopharmaceuticals Suzhou Co. Ltd. and Sinovac Biotechnology to investigate the safety, tolerability, and immunogenicity of different... Read More »
President Joe Biden approved more than $3.46 billion Thursday for Hazard Mitigation Grants to increase state’s resilience to the impacts of climate change.
The investment will be available for natural hazard mitigation measures across the 59 major disaster declarations issued due to the... Read More »
U.S. Sen. Tammy Baldwin (D-WI) introduced legislation last week that would allocate $2 billion to the Biomedical Advanced Research and Development Authority (BARDA).
The Disease X Act would provide $2 billion over the next four years -- $500 million per year, beginning in 2022 -- for BARDA to... Read More »
A cocktail of casirivimab and imdevimab known as REGEN-COV, produced by Regeneron Pharmaceuticals, Inc., cut the risk of symptomatic infections by 81 percent in a Phase 3 trial of more than 1,500 people, according to a new publication in the New England Journal of Medicine.
Even better,... Read More »
A new report released this week by United States Sens. Rob Portman (R-OH) and Gary Peters (D-MI) revealed glaring cybersecurity failures at eight federal agencies over the past decade, along with the inability of seven of them to comply with basic cybersecurity requirements.
The Federal... Read More »
In a letter dispatched last week, five U.S. representatives called on Health and Human Services Secretary Xavier Becerra to tap domestic manufacturing and new technologies to grow the national stockpile of important pharmaceuticals and reduce reliance on foreign production.
Although the... Read More »
REGEN-COV was confirmed for continued use against COVID-19 cases deemed at high risk for progression to hospitalization or death last week, with the extension of its Emergency Use Authorization by the United States Food and Drug Administration (FDA).
The therapeutic is a monoclonal antibody... Read More »
Following a new National Security Memorandum signed by President Joe Biden aimed at strengthening cybersecurity for the nation’s critical infrastructure, a bipartisan group of U.S. senators recently introduced the Defense of United States Infrastructure Act, S. 2491, legislation aimed at... Read More »
State funding for public health departments has dropped by 16 percent since 2010, and these same departments have lost a quarter of their workforce in the last decade.
How can the United States adequately prepare for the next pandemic when the public health infrastructure is woefully... Read More »
In a first for virus detection, the company Opteev this week launched a plug-in airborne virus detector known as ViraWarn to scan for COVID-19, flu, and other virus particles in the air indoors and then warn those who might be affected.
Meant as prevention rather than confirmation of infection,... Read More »
Recognizing that many data sets are needed to tell the full story of the COVID-19 pandemic and understand if herd immunity can be achieved, two scientists from the University of Washington have created a statistical model of key COVID-19 data to model the disease’s true prevalence in the United... Read More »
In a letter written to Senate Majority Leader Chuck Schumer (D-NY) and Speaker of the House Nancy Pelosi (D-CA), more than 70 U.S. representatives and senators have called for providing up to $34 billion to speed up COVID-19 vaccine production for global use.
“No investment in the fight... Read More »
Drawing on funds from the American Rescue Plan, the Biden administration announced last week that its Department of Health and Human Services (HHS) will invest more than $1.6 billion into testing and mitigation efforts focused on the communities most vulnerable to COVID-19.
“As we continue... Read More »
U.S. Sens. Mark Warner (D-VA), Marco Rubio (R-FL), and Susan Collins (R-ME) introduced Wednesday the Cyber Incident Notification Act of 2021, which seeks to make it mandatory for federal agencies, government contractors, and critical infrastructure to report cyber intrusions to the Cybersecurity... Read More »
Pushing back against the string of cybersecurity threats instigated this year, the United States Transportation Security Administration (TSA) issued a new Security Directive this week that requires owners and operators of critical pipelines to roll out urgent cyber protections.
“Secure... Read More »
On Monday, the Infectious Diseases Society of America commended the U.S. House for appropriations that would bolster the fight against COVID-19 and HIV, antibiotic research and development, and global health security while combating the effects of the opioid crisis.
However, the organization... Read More »
Given the destructive nature of the past year and a half under the COVID-19 pandemic, U.S. Rep. Eric Swalwell (D-CA) last week introduced two bills to strengthen pandemic response and treat them as national security threats rather than political minefields.
First was the National Security... Read More »
Partners in COVAX, a global collaborative effort to accelerate development, manufacturing and equitable access to COVID-19 vaccines, launched the COVAX Marketplace last week to match buyers with suppliers through a secure new platform and overcome short-term bottlenecks.
The Marketplace is a... Read More »
U.S. Surgeon General Dr. Vivek Murthy recently issued the first Surgeon General's Advisory of this administration warning of the urgent dangers posed by health misinformation and disinformation, threatening COVID-19 vaccination efforts in the United States.
The American public needs to be aware... Read More »
A total of $153 million was split between two projects under the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIMBL) this week, as awarded by the United States Department of Commerce’s National Institute of Standards and Technology (NIST).
“I am so pleased that... Read More »
On Tuesday, the U.S. House of Representatives Appropriations Committee approved the Defense Funding bill for FY 2022 on a 33-23 vote.
The bill provides $705.9 billion in defense spending, an increase of 1.4 percent over 2021’s budget. The increase reflects President Joe Biden’s budget... Read More »
A congressional panel began the formal process of investigating the origins of Covid-19 Wednesday amid recriminations over allegations of researchers being intentionally misled by the Chinese government and American media and politicians.
U.S. Rep. Michael Waltz (R-FL) labeled it “a bit... Read More »
After an eight-month void in official leadership, the U.S. Senate this week confirmed former Obama-era senior National Security Agency official Jen Easterly to lead the Cybersecurity and Infrastructure Security Agency (CISA) amid increasingly frequent digital attacks.
Easterly, who formerly... Read More »
The Bipartisan Commission on Biodefense urged Congress to take action to protect the country’s critical infrastructure from biological threats on Wednesday.
In two recent reports, The Apollo Program for Biodefense: Winning the Race Against Biological Threats, and Biodefense in Crisis:... Read More »
Questions were spurred last week with news from Pfizer and BioNTech that progress was being made on a COVID-19 vaccine booster the companies indicated would likely be needed in the future -- a stance promptly contradicted by the U.S. Food and Drug Administration (FDA) and the Centers for Disease... Read More »
A recent study by scientists at the National Institutes of Health suggests that one in every four COVID-19 deaths in the United States may be attributed to hospitals strained by surging caseloads.
Published in the Annals of Internal Medicine, the study looked at data from 150,000 COVID-19... Read More »
Is the United States prepared for the next pandemic?
That question has forced experts to either rethink preparedness strategies or find ways to bolster existing policy in the era of COVID-19.
For the researchers at the Johns Hopkins Center for Health Security, this has meant identifying 13... Read More »
The U.S. Department of Homeland Security (DHS) this week awarded $997,526 to SecureLogix, a San Antonio, Texas-based small business, for Next Generation 9-1-1 technology meant to help secure data during emergencies.
Data, in this case, refers to text, images, video, and traditional voice calls... Read More »
A nationwide study from the University of Utah found that those who receive mRNA COVID-19 vaccines are 91 percent less likely to develop the disease than those who are unvaccinated.
This news came from the RECOVER (Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel)... Read More »
In an effort to keep transportation safe without slowing the flow of traffic, the New York City subway system, together with a series of collaborators in the federal, academic, and private sectors, is rolling out a testbed and series of biosensors to scan for chemical and biological threats.... Read More »
Looking to address a medical need and reduce development and preparedness costs for taxpayers, the Biomedical Advanced Research and Development Authority (BARDA) has purchased and begun accepting the Paratek Pharmaceuticals antibiotic NUZYRA for use on anthrax infections.
The contract could... Read More »
Denouncing further spending on the nuclear Ground Based Strategic Deterrent (GBSD) program as unnecessary, costly, and promoting a nuclear arms race, U.S. Rep. John Garamendi (D-CA) has introduced legislation to pause development until 2031 and extend the lifespan of existing weapons.
“As a... Read More »
Moderna, Inc. released a clinical update of a small Phase 1 trial this week evaluating the performance of its mRNA COVID-19 vaccine against three of the ever-multiplying strains of the disease, including the worrisome Delta variant.
Based on serum samples from eight vaccinated participants,... Read More »
Antibiotics underpin modern medicine— used to treat everything from bacterial infections to cancer.
However, a world without effective antibiotics because of antimicrobial resistance (AMR) could mean the unraveling of health care. It also has implications for national security as antibiotics... Read More »
